{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:39Z","timestamp":1791928899170,"version":"4.3.4"},"reference-count":52,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"15","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,12,5]]},"DOI":"10.1167\/iovs.66.15.24","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:30:37Z","timestamp":1764945037000},"page":"24","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Pegcetacoplan on Aqueous Humor Proteome in Geographic Atrophy: A Prospective Exploration"],"prefix":"10.1167","volume":"66","author":[{"given":"Omer","family":"Trivizki","sequence":"first","affiliation":[{"name":"Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel"},{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Wykoff","sequence":"additional","affiliation":[{"name":"Retina Consultants of Texas, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda A.","family":"Smoor","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands"},{"name":"Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rabinovitch","sequence":"additional","affiliation":[{"name":"Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"Zhou","sequence":"additional","affiliation":[{"name":"Retina Consultants of Texas, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Cao","sequence":"additional","affiliation":[{"name":"Retina Consultants of Texas, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara T. E.","family":"Lechanteur","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert","family":"van den Heuvel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Radboud Institute for Molecular Life Sciences, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"Department of Pediatrics\/Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium"},{"name":"Department of Development and Regeneration, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain J.","family":"van Gool","sequence":"additional","affiliation":[{"name":"Translational Metabolic Laboratory, Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolein","family":"Gloerich","sequence":"additional","affiliation":[{"name":"Translational Metabolic Laboratory, Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle E.","family":"Vergroesen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands"},{"name":"Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C. W.","family":"Klaver","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands"},{"name":"Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands"},{"name":"Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.61.3.18","article-title":"Complement activation levels are related to disease stage in AMD","volume":"61","author":"Heesterbeek","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.42671","article-title":"Complement","volume":"76","author":"Monach","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ophtha.2020.11.024","article-title":"Genetic risk, lifestyle, and age-related macular degeneration in Europe: the EYE-RISK Consortium","volume":"128","author":"Colijn","year":"2021","journal-title":"Ophthalmology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.3390\/jcm10132890","article-title":"Complement inhibition for geographic atrophy: a tempting target with mixed results","volume":"10","author":"Lin","year":"2021","journal-title":"J Clin Med"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"e93459","DOI":"10.1371\/journal.pone.0093459","article-title":"Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels","volume":"9","author":"Ristau","year":"2014","journal-title":"PLoS One"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","article-title":"An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration","volume":"20","author":"Hageman","year":"2001","journal-title":"Prog Retin Eye Res"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1038\/s41433-018-0170-8","article-title":"Evaluation of serum and ocular levels of membrane attack complex and C-reactive protein in CFH-genotyped human donors","volume":"32","author":"Chirco","year":"2018","journal-title":"Eye (Lond)"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1167\/iovs.09-3928","article-title":"Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes","volume":"50","author":"Reynolds","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"eaaf1443","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.oret.2020.01.019","article-title":"Visual function decline resulting from geographic atrophy: results from the Chroma and Spectri phase 3 trials","volume":"4","author":"Heier","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/prca.201400133","article-title":"Vitreous humor in the pathologic scope: insights from proteomic approaches","volume":"9","author":"Monteiro","year":"2015","journal-title":"Proteomics Clin Appl"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"e96895","DOI":"10.1371\/journal.pone.0096895","article-title":"Proteomics of vitreous humor of patients with exudative age-related macular degeneration","volume":"9","author":"Koss","year":"2014","journal-title":"PLoS One"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.exer.2016.01.001","article-title":"Proteomics of vitreous in neovascular age-related macular degeneration","volume":"146","author":"Nobl","year":"2016","journal-title":"Exp Eye Res"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"AMD31","DOI":"10.1167\/iovs.18-24122","article-title":"The proteomic landscape in the vitreous of patients with age-related and diabetic retinal disease","volume":"59","author":"Schori","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.11.4.13","article-title":"Correlation of complement activation in aqueous and vitreous in patients with proliferative diabetic retinopathy","volume":"11","author":"Smith","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.62.10.18","article-title":"Analysis of the aqueous humor proteome in patients with age-related macular degeneration","volume":"62","author":"Rinsky","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.13.11.13","article-title":"Ocular pharmacodynamics of intravitreal faricimab in patients with neovascular age-related macular degeneration or diabetic macular edema","volume":"13","author":"Diack","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"31951","DOI":"10.1038\/s41598-024-83473-6","article-title":"Analysis of the aqueous humor before and after the administration of faricimab in patients with nAMD","volume":"14","author":"Nonogaki","year":"2024","journal-title":"Sci Rep"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1167\/tvst.13.12.35","article-title":"Changes in aqueous angiopoietin-1\/2 concentrations during the induction phase of intravitreal faricimab injections for diabetic macular edema","volume":"13","author":"Shimura","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3390\/nu15030602","article-title":"Lifestyle intervention randomized controlled trial for age-related macular degeneration (AMD-Life): study design","volume":"15","author":"de Koning-Backus","year":"2023","journal-title":"Nutrients"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ebiom.2019.06.008","article-title":"Biosynthetic homeostasis and resilience of the complement system in health and infectious disease","volume":"45","author":"Willems","year":"2019","journal-title":"eBioMedicine"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1074\/mcp.TIR118.000853","article-title":"A novel LC system embeds analytes in pre-formed gradients for rapid, ultra-robust proteomics","volume":"17","author":"Bache","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat Methods"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaophthalmol.2017.4097","article-title":"Potential of aqueous humor as a surrogate tumor biopsy for retinoblastoma","volume":"135","author":"Berry","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","article-title":"Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients","volume":"243","author":"Funatsu","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.61.2.26","article-title":"Correlation of aqueous, vitreous, and plasma cytokine levels in patients with proliferative diabetic retinopathy","volume":"61","author":"Wu","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12967-024-05909-x","article-title":"Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study","volume":"23","author":"Schikora","year":"2025","journal-title":"J Transl Med"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00417-020-04910-6","article-title":"Association of imaging biomarkers and local activation of complement in aqueous humor of patients with early forms of age-related macular degeneration","volume":"259","author":"Sitnilska","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/jpm13091400","article-title":"Complement system proteins in the human aqueous humor and their association with primary open-angle glaucoma","volume":"13","author":"Vashishtha","year":"2023","journal-title":"J Pers Med"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.12.11.9","article-title":"Correlation of aqueous, vitreous, and serum protein levels in patients with retinal diseases","volume":"12","author":"Wilson","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3390\/jpm11121256","article-title":"Semi-quantitative multiplex profiling of the complement system identifies associations of complement proteins with genetic variants and metabolites in age-related macular degeneration","volume":"11","author":"Acar","year":"2021","journal-title":"J Pers Med"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.survophthal.2017.05.003","article-title":"Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration","volume":"63","author":"Kersten","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/tvst.11.5.22","article-title":"Sex and age-related differences in complement factors among patients with intermediate age-related macular degeneration","volume":"11","author":"Marin","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/ajh.25960","article-title":"C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab","volume":"95","author":"de Castro","year":"2020","journal-title":"Am J Hematol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1182\/blood-2011-02-339564","article-title":"\u00df2-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator","volume":"118","author":"Gropp","year":"2011","journal-title":"Blood"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.4049\/jimmunol.2000570","article-title":"Complement activation and thrombin generation by MBL bound to \u00df2-glycoprotein I","volume":"205","author":"Durigutto","year":"2020","journal-title":"J Immunol"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/ars.2014.6052","article-title":"Do beta 2-glycoprotein I disulfide bonds protect the human retina in the setting of age-related macular degeneration?","volume":"24","author":"Qi","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ph13060130","article-title":"Differential expression of kinin receptors in human wet and dry age-related macular degeneration retinae","volume":"13","author":"Othman","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/ijms19020330","article-title":"Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea","volume":"19","author":"Terzuoli","year":"2018","journal-title":"Int J Mol Sci"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"e20036","DOI":"10.1371\/journal.pone.0020036","article-title":"Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1","volume":"6","author":"Dobo","year":"2011","journal-title":"PLoS One"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1128\/AAC.00322-13","article-title":"Kallistatin modulates immune cells and confers anti-inflammatory response to protect mice from group A streptococcal infection","volume":"57","author":"Lu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molimm.2015.02.014","article-title":"MASP-1 of the complement system promotes clotting via prothrombin activation","volume":"65","author":"Jenny","year":"2015","journal-title":"Mol Immunol"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fimmu.2020.00794","article-title":"Patterns of C1-inhibitor\/plasma serine protease complexes in healthy humans and in hereditary angioedema patients","volume":"11","author":"Kajdacsi","year":"2020","journal-title":"Front Immunol"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"878199","DOI":"10.3389\/fcvm.2022.878199","article-title":"Anticoagulant SERPINs: endogenous regulators of hemostasis and thrombosis","volume":"9","author":"Grover","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.ophtha.2021.02.025","article-title":"Characterizing new-onset exudation in the randomized phase 2 FILLY trial of complement inhibitor pegcetacoplan for geographic atrophy","volume":"128","author":"Wykoff","year":"2021","journal-title":"Ophthalmology"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:00Z","timestamp":1791927120000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":52,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.15.24","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}